1
Clinical Trials associated with Mesenchymal Stromal Cells(Banc de Sang i Teixits)A Phase IIa, Single Center, Prospective, Randomized, Parallel, Two-arms, Single-dose, Open-label With Blinded Assessor Pilot Clinical Trial to Assess ex Vivo Expanded Adult Autologous Mesenchymal Stromal Cells Fixed in Allogeneic Bone Tissue (XCEL-MT-OSTEO-ALPHA) in Non Hypertrophic Pseudoarthrosis of Long Bones
The present study evaluates the effect of XCEL-MT-OSTEO-ALPHA in non-union fractures (pseudoarthrosis) of long bones in comparison to the standard treatment of autologous iliac crest.
XCEL-MT-OSTEO-ALPHA is a tissue engineering product composed by "ex-vivo" expanded autologous mesenchymal stromal cells fixed in allogenic bone tissue, produced by Xcelia (Blood and Tissue Bank of Catalonia).
The working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration up to consolidation of non-union fractures.
100 Clinical Results associated with Mesenchymal Stromal Cells(Banc de Sang i Teixits)
100 Translational Medicine associated with Mesenchymal Stromal Cells(Banc de Sang i Teixits)
100 Patents (Medical) associated with Mesenchymal Stromal Cells(Banc de Sang i Teixits)
100 Deals associated with Mesenchymal Stromal Cells(Banc de Sang i Teixits)